Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia

Normal and aberrant immune receptor gene assembly each produce site-specific DNA rearrangements in leukemic lymphoblasts. In either case, these rearrangements provide useful clonal markers for the leukemias in question. In the t(1;14)(p34;q11) translocation associated with T cell acute lymphoblastic leukemia (T-ALL), the breakpoints on chromosome 1 interrupt the tal-1 gene. A site-specific deletion interrupts the same gene in an additional 26% of T-ALL. Thus, nearly one-third of these leukemias contain clustered rearrangements of the tal-1 locus. To test whether these rearrangements can serve as markers for residual disease, we monitored four patients with T-ALL; three of the leukemias contained a deleted (tal^d) and one a translocated (tal^t) tal-1 allele. These alleles were recognized by a sensitive amplification/hybridization assay. tal^d alleles were found in the blood of one patient during the 4th mo of treatment but not thereafter. Using a quantitative assay to measure the fraction of tal^d alleles in DNA extracts, we estimated that this month 4 sample contained 150 tal^d copies per 10⁶ genome copies. The patient with t(1;14)(p34;q11) (tal^t) leukemia developed a positive assay during the 20th mo of treatment. By standard criteria, all four patients remain in complete remission 11-20 mo into treatment. We conclude that tal-1 rearrangements provide useful clonal markers for ∼ 30% of T-ALLs.